Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (21-30 of 401) with videos related to

Pageof 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Temsirolimus, an inhibitor of mammalian target of rapamycinBrian I Rini
Urologic Oncology|February 10, 2015
Toward individualized treatment in urologic oncologyBrian I Rini
Clinical Advances in Hematology & Oncology : H&O|August 25, 2010
Biomarkers: hypertension following anti-angiogenesis therapyBrian I Rini
Journal of Oncology Practice|May 13, 2016
Changing Landscape of Refractory Renal Cell CarcinomaBrian I Rini
The Oncologist|March 29, 2005
VEGF-targeted therapy in metastatic renal cell carcinomaBrian I Rini
Current Oncology Reports|March 2, 2006
VEGF-targeted therapy in renal cell carcinoma: active drugs and active choicesBrian I Rini
The Lancet. Oncology|February 2, 2008
Quantifying hypertension in patients with cancer treated with sorafenibBrian I Rini
Nature Clinical Practice. Urology|January 24, 2008
Is sorafenib plus interferon alpha 2b safe and effective in patients with renal cell carcinoma?Brian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directionsBrian I Rini
Nature Clinical Practice. Oncology|November 3, 2006
Stabilization of disease in patients with metastatic renal cell carcinoma using sorafenibBrian I Rini
Pageof 41

Showing results (21-30 of 401) with videos related to

Sort By:
Pageof 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Temsirolimus, an inhibitor of mammalian target of rapamycinBrian I Rini
Urologic Oncology|February 10, 2015
Toward individualized treatment in urologic oncologyBrian I Rini
Clinical Advances in Hematology & Oncology : H&O|August 25, 2010
Biomarkers: hypertension following anti-angiogenesis therapyBrian I Rini
Journal of Oncology Practice|May 13, 2016
Changing Landscape of Refractory Renal Cell CarcinomaBrian I Rini
The Oncologist|March 29, 2005
VEGF-targeted therapy in metastatic renal cell carcinomaBrian I Rini
Current Oncology Reports|March 2, 2006
VEGF-targeted therapy in renal cell carcinoma: active drugs and active choicesBrian I Rini
The Lancet. Oncology|February 2, 2008
Quantifying hypertension in patients with cancer treated with sorafenibBrian I Rini
Nature Clinical Practice. Urology|January 24, 2008
Is sorafenib plus interferon alpha 2b safe and effective in patients with renal cell carcinoma?Brian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directionsBrian I Rini
Nature Clinical Practice. Oncology|November 3, 2006
Stabilization of disease in patients with metastatic renal cell carcinoma using sorafenibBrian I Rini
Pageof 41